The Pharmaceutical Grade CBD approved by the FDA and found in clinical trials to be effective against conditions such as epilepsy is “not the same” as marijuana products purchased from coffeeshop or cannabis stores.

That is the warning from Shlomo Shinnar, professor of neurology and epidemiology at the Albert Einstein College of Medicine and president of American Epilepsy Society